Re-thinking metabolic strategies for older people with type 2 diabetes mellitus: Implications of the UK Prospective Diabetes Study and other recent studies

Age and Ageing

Volumn 29, Issue 5, 2000, Pages 393-397

  Sinclair, Alan J ^a   Meneilly, Graydon S ^b  

^a SELLY OAK HOSPITAL   (United Kingdom)

^b VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CHLORPROPAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; PRAVASTATIN; SIMVASTATIN; SULFONYLUREA;

AGED; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC RETINOPATHY; DIET THERAPY; ELDERLY CARE; HEALTH CARE COST; HUMAN; HYPERTENSION; HYPOGLYCEMIA; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA MACULOPATHY; UNITED KINGDOM; VISUAL ACUITY; VISUAL IMPAIRMENT; WEIGHT GAIN;

AGE FACTORS; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; GERIATRIC ASSESSMENT; GREAT BRITAIN; HUMANS; PRACTICE GUIDELINES; PROSPECTIVE STUDIES; RESEARCH DESIGN; RISK FACTORS; TREATMENT OUTCOME;

EID: 0033729013     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (32)

1. UK Prospective Diabetes Study 33: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
2. UK Prospective Diabetes Study 38: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38)
3. UKPDS: Implications for the care of people with type 2 diabetes
4. UK Prospective Diabetes Study 34: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
5. Commentary: Some answers, more controversy from UKPDS
6. Diabetes in the elderly
7. Contraindications to metformin therapy in patients with NIDDM
8. UK Prospective Diabetes Study 39: Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 39)
9. MRC trial of treatment of hypertension: Principal results
10. Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension)
11. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)
12. Functional status and quality of life measurement among ophthalmic patients
13. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension
14. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension
15. NIDDM and its metabolic control predict coronary heart disease in elderly subjects
16. Diabetic control and progression of retinopathy in elderly patients: Five-year follow-up study
17. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus
18. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes
19. Counterregulatory hormone responses to hypoglycaemia in the elderly patient with diabetes
20. Lack of knowledge of symptoms of hypoglycaemia by elderly diabetic patients
21. Improving the care of elderly diabetic patients: The final report of the St Vincent joint task force for diabetes
22. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
23. The Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol-lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Study (4S)
24. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
25. Model of complications of NIDDM
26. Model of complications of NIDDM
27. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes
28. Use of hospital services by elderly patients with diabetes
29. Hospitalisation and mortality of diabetes in older adults
30. The cost to health plans of poor glycaemic control
31. Developing risk stratification charts for diabetic and non-diabetic subjects